On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...